BNP Paribas Exane Has Lowered Expectations for Petco Health and Wellness (NASDAQ:WOOF) Stock Price

Petco Health and Wellness (NASDAQ:WOOF) had its price objective decreased by analysts at BNP Paribas Exane from $2.34 to $2.11 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has an “underperform” rating on the stock. BNP Paribas Exane’s target price would indicate a potential downside of 18.38% from the company’s current price.

Several other equities research analysts have also recently commented on WOOF. Zacks Research cut shares of Petco Health and Wellness from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 18th. Weiss Ratings restated a “sell (d)” rating on shares of Petco Health and Wellness in a report on Thursday, June 11th. Citigroup lowered their target price on shares of Petco Health and Wellness from $4.00 to $3.25 and set a “neutral” rating for the company in a report on Thursday, June 4th. Wall Street Zen upgraded shares of Petco Health and Wellness from a “hold” rating to a “buy” rating in a research report on Saturday, July 4th. Finally, Robert W. Baird increased their price target on Petco Health and Wellness from $3.00 to $3.25 and gave the company a “neutral” rating in a research note on Thursday. One investment analyst has rated the stock with a Buy rating, six have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, Petco Health and Wellness presently has an average rating of “Reduce” and a consensus price target of $3.42.

Petco Health and Wellness Price Performance

Shares of Petco Health and Wellness stock traded down $0.04 during mid-day trading on Thursday, reaching $2.58. 7,384,318 shares of the stock were exchanged, compared to its average volume of 2,144,988. Petco Health and Wellness has a fifty-two week low of $2.24 and a fifty-two week high of $3.96. The company has a market cap of $835.88 million, a price-to-earnings ratio of 128.81, a price-to-earnings-growth ratio of 2.99 and a beta of 1.53. The firm has a 50-day simple moving average of $2.71 and a 200 day simple moving average of $2.74. The company has a current ratio of 0.85, a quick ratio of 0.29 and a debt-to-equity ratio of 1.27.

Petco Health and Wellness (NASDAQ:WOOF) last issued its quarterly earnings data on Wednesday, September 2nd. The company reported $0.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.06. The firm had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.49 billion. Petco Health and Wellness had a return on equity of 1.36% and a net margin of 0.09%.During the same quarter in the previous year, the company posted $0.05 EPS. On average, sell-side analysts predict that Petco Health and Wellness will post 0.09 EPS for the current fiscal year.

Insider Buying and Selling at Petco Health and Wellness

In other news, insider Holly May sold 200,000 shares of the stock in a transaction on Thursday, July 9th. The shares were sold at an average price of $2.54, for a total transaction of $508,000.00. Following the completion of the sale, the insider owned 1,327,867 shares of the company’s stock, valued at $3,372,782.18. This represents a 13.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders have sold a total of 450,000 shares of company stock valued at $1,145,500 in the last ninety days. 6.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. AQR Capital Management LLC boosted its holdings in Petco Health and Wellness by 9.1% during the first quarter. AQR Capital Management LLC now owns 1,274,588 shares of the company’s stock worth $3,887,000 after purchasing an additional 106,295 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in Petco Health and Wellness by 60.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 3,637,695 shares of the company’s stock worth $11,095,000 after purchasing an additional 1,367,299 shares during the last quarter. Creative Planning increased its holdings in shares of Petco Health and Wellness by 14.8% during the second quarter. Creative Planning now owns 36,779 shares of the company’s stock worth $104,000 after purchasing an additional 4,734 shares during the period. Cetera Investment Advisers lifted its holdings in shares of Petco Health and Wellness by 17.6% during the 2nd quarter. Cetera Investment Advisers now owns 28,419 shares of the company’s stock worth $80,000 after acquiring an additional 4,258 shares during the period. Finally, Legal & General Group Plc boosted its holdings in shares of Petco Health and Wellness by 23.9% during the 2nd quarter. Legal & General Group Plc now owns 126,352 shares of the company’s stock valued at $358,000 after acquiring an additional 24,369 shares in the last quarter.

Key Headlines Impacting Petco Health and Wellness

Here are the key news stories impacting Petco Health and Wellness this week:

• Positive Sentiment: Petco reported fiscal Q2 adjusted EPS of $0.13, ahead of the $0.07 analyst consensus and up from $0.05 a year earlier. The company also delivered its second consecutive quarter of positive comparable-sales growth and said profitability came in ahead of its outlook. Petco Reports Second Quarter 2026 Results
• Positive Sentiment: Management announced a $75 million debt prepayment, advancing its goal of reaching 2.0 times leverage. Improved consumables and services performance, along with early traction from omnichannel initiatives and expanded services, supports the company’s turnaround narrative. The Market Is Finally Starting To Come Around to Petco Health and Wellness Company
• Positive Sentiment: Petco forecast fiscal 2026 adjusted EBITDA of $415 million to $430 million and reaffirmed its overall outlook, while quarterly revenue of approximately $1.49 billion matched expectations. Petco Fiscal 2026 EBITDA Forecast
• Neutral Sentiment: Robert W. Baird raised its price target from $3.00 to $3.25 but retained a Neutral rating, signaling increased valuation potential without a firm bullish recommendation.
• Neutral Sentiment: UBS maintained a Neutral rating while lowering its target from $4.00 to $3.50. The revised target still implies substantial potential upside, but the cut reflects more cautious expectations.
• Negative Sentiment: Revenue was essentially flat year over year, and management’s sales outlook calls for flat to only 1.5% growth. Profit improvement was also aided in part by a one-time tariff refund, raising questions about how durable the earnings gains will be. Petco Fiscal Q2 Sales Results

About Petco Health and Wellness

Petco Health and Wellness Company, Inc (NASDAQ: WOOF) is a leading U.S. pet specialty retailer focused on delivering products, services and solutions that improve the health and well-being of pets. The company operates a network of retail locations that provide high-quality pet food, supplies and accessories, along with a growing digital platform that supports online ordering, subscription delivery and telehealth consultations for pets.

In addition to its retail offerings, Petco has built a full suite of in-store and virtual services, including grooming, training, dog daycare and veterinary care.